3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Brain Neoplasms
23
Lung Neoplasms
17
Neoplasm Metastasis
15
Breast Neoplasms
12
Melanoma
9
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Neoplasms
3
NSCLC
3
Meningioma
3
Gastrointestinal Neoplasms
3
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Platinum
6
Cisplatin
6
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
3
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Radiosurgery
×
90 days
×
Clear all
No trials found.